Modular organization of SARS coronavirus nucleocapsid protein
✍ Scribed by Chung-ke Chang; Shih-Che Sue; Tsan-hung Yu; Chiu-Min Hsieh; Cheng-Kun Tsai; Yen-Chieh Chiang; Shin-jye Lee; Hsin-hao Hsiao; Wen-Jin Wu; Wei-Lun Chang; Chun-Hung Lin; Tai-huang Huang
- Publisher
- BioMed Central
- Year
- 2005
- Tongue
- English
- Weight
- 616 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1021-7770
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract **BACKGROUND:** Globally, severe acute respiratory syndrome coronavirus (SARS‐CoV) is a newly emerging virus that causes SARS with high mortality rate in infected people. The nucleocapsid (N) protein of the severe acute respiratory syndrome (SARS)‐associated coronavirus (SARS‐CoV) is an
## Abstract A high throughput accurate assay for anti‐SARS‐CoV IgG detection is needed for large‐scale epidemiological studies. The evaluation of a commercial recombinant nucleocapsid protein‐based microtitre plate enzyme immunoassay, ELISARS™ is described. The results on 150 sera from SARS patient
SARS-CoV is a newly identified coronavirus (CoV) that causes severe acute respiratory syndrome (SARS). The SARS-CoV nucleocapsid (N) protein is an important structural and functional protein. To identify cellular proteins that interact with the SARS-CoV N protein and to elucidate the possible involv
## Abstract Severe acute respiratory syndrome (SARS)‐CoV is a newly emerging virus that causes SARS with high mortality rate in infected people. To study the humoral responses against SARS‐CoV, we evaluated nucleocapsid (N) and spike (S) proteins‐specific antibodies in patients' sera by Western blo